Does IPILIMUMAB Cause Hepatic function abnormal? 492 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 492 reports of Hepatic function abnormal have been filed in association with IPILIMUMAB (YERVOY). This represents 1.4% of all adverse event reports for IPILIMUMAB.
492
Reports of Hepatic function abnormal with IPILIMUMAB
1.4%
of all IPILIMUMAB reports
108
Deaths
334
Hospitalizations
How Dangerous Is Hepatic function abnormal From IPILIMUMAB?
Of the 492 reports, 108 (22.0%) resulted in death, 334 (67.9%) required hospitalization, and 60 (12.2%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
Yes, Hepatic function abnormal is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which IPILIMUMAB Alternatives Have Lower Hepatic function abnormal Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN